Pharma Foods International Co., Ltd.

2929・Prime Market・Foods

2929・Prime Market・Foods

Pharma Foods International Co., Ltd.2929

Reference Indicators

Market Cap

201¥100M

P/E (Forecast)

9.1x

P/B

1.5x

Dividend Yield (Forecast)

3.61%

ROE

16.1%

EV/EBITDA

8.8x

Financial Summary

Unit: ¥M

Item	2022Jul 2022	2023Jul 2023	2024Jul 2024	2025Jul 2025	2026Jul 2026
Net Sales	60,185	68,572	62,147	65,260	63,223
Cost of Sales	12,077	13,293	13,395	12,676	12,530
Gross Profit	48,108	55,279	48,751	52,583	50,693
SG&A Expenses	47,028	51,669	43,638	50,215	48,060
Operating Income	1,080	3,610	5,113	2,367	2,632
Non-operating Income	228	169	285	472	373
Non-operating Expenses	43	239	150	286	565
Ordinary Income	1,264	3,540	5,249	2,553	2,440
Extraordinary Income	160	8	10	—	4
Extraordinary Losses	1	6	225	118	117
Pre-tax Income	1,423	3,542	5,034	2,434	2,327
Income Taxes	1,797	462	1,828	2,066	338
Net Income	-374	3,081	3,205	368	1,988
EBITDA	1,600	4,156	6,020	3,152	3,368
Gross Margin	79.9%	80.6%	78.4%	80.6%	80.2%
Operating Margin	1.8%	5.3%	8.2%	3.6%	4.2%
ROA	-1.2%	8.5%	8.8%	1.1%	5.7%
ROE	-4.8%	36.9%	30.2%	3.2%	16.1%

Segment Performance

Unit: ¥M

2025

Segment	Net Sales	Operating Income	Operating Margin
Bto B事業	8,182	1,248	15.3%
Bto C事業	56,730	3,703	6.5%
バイオメディカル事業	331	-378	-114.2%
その他	15	-10	-66.7%

Disclaimer